中国免疫学杂志2024,Vol.40Issue(10):2207-2213,7.DOI:10.3969/j.issn.1000-484X.2024.10.032
间充质干细胞在复发性自然流产中治疗潜能的研究进展
Research progress on therapeutic potential of mesenchymal stem cells in recurrent spontaneous abortion
摘要
Abstract
Recurrent spontaneous abortion(RSA)is one of the most common complications in early pregnancy,affecting about 2%~5%of women of childbearing age,and its incidence is increasing year by year,which not only affects women's physical and mental health,but also causes a heavy economic burden to the society and the family.Mesenchymal stem cells(MSCs)are a class of non-hematopoietic adult multipotent stem cells derived from mesodermal mesenchymal cells of a variety of tissues.They have the characteristics of multi-directional differentiation and self-renewal,and can improve the fertility outcome of RSA patients,which has become a research hotspot in recent years.Therefore,this paper explores the roles and mechanisms of MSCs from different sources in improving pregnancy outcomes in RSA patients,and analyzes their research status and existing problems.关键词
间充质干细胞/复发性自然流产/干细胞治疗Key words
Mesenchymal stem cells/Recurrent spontaneous abortion/Stem cell therapy分类
医药卫生引用本文复制引用
王清仪,刘晓芳,冯晓玲..间充质干细胞在复发性自然流产中治疗潜能的研究进展[J].中国免疫学杂志,2024,40(10):2207-2213,7.基金项目
国家自然科学基金面上项目(81973894,82174421). (81973894,82174421)